Rep. Raul Ruiz appointed Ranking Member of the Select Subcommittee on the Coronavirus Pandemic
Local Congressman Dr. Raul Ruiz has been appointed as a Ranking Member of the Select Subcommittee on the Coronavirus Pandemic.
House Democratic Leader Hakeem Jeffries appointed Ruiz to the position on Tuesday.
Ruiz issued the following statement:
“I am honored to have been appointed by Democratic Leader Jeffries to serve as Ranking Member of the Select Subcommittee on the Coronavirus Pandemic. As a physician and public health expert, I will take an equity-based and patient-centered approach to put people above politics and identify common-sense solutions that will protect our nation’s health.”
Jeffries appointed also appointed the following democrats to the subcommittee:
Rep. Debbie Dingell (MI-06)
Rep. Kweisi Mfume (MD-07)
Rep. Robert Garcia (CA-42)
Republican House Leader Kevin McCarthy appointed the following Republican representative to the subcommittee:
Chairman Brad Wenstrup (OH-02)
Rep. Nicole Malliotakis (NY-11)
Rep. Mariannette Miller Meeks (IA-01)
Rep. Debbie Lesko (AZ-08)
Rep. Michael Cloud (TX-27)
Rep. John Joyce (PA-13)
Rep. Marjorie Taylor Greene (GA-14)
Rep. Ronny Jackson (TX-13)
Rep. Rich McCormick (GA-06)
The Select Subcommittee on the Coronavirus Crisis was established by the House on April 23, 2020. It's modeled after Senator Harry Truman’s Special Committee to Investigate the National Defense Program, which oversaw defense spending as the entire nation mobilized for World War II.
(1) the efficiency, effectiveness, equity, and transparency of the use of taxpayer funds and relief programs to address the coronavirus crisis, including through Federal agencies, State and local government entities, financial institutions and other private businesses, contracts, grants, loans, loan guarantees, investments, cooperative agreements, or any other means;
(2) reports of waste, fraud, abuse, price gouging, profiteering, or other abusive practices related to the coronavirus crisis;
(3) the implementation or effectiveness of any Federal law applied, enacted, or under consideration to address the coronavirus crisis and prepare for future pandemics;
(4) preparedness for and response to the coronavirus crisis, including the planning for and implementation of testing, containment, mitigation, and surveillance activities; the acquisition, distribution, or stockpiling of protective equipment and medical supplies; and the development of vaccines and treatments;
(5) the economic impact of the coronavirus crisis on individuals, communities, small businesses, health care providers, States, and local government entities;
(6) any disparate impacts of the coronavirus crisis on different communities and populations, including with respect to race, ethnicity, age, sex, gender identity, sexual orientation, disability, and geographic region, and any measures taken to address such disparate impacts;
(7) executive branch policies, deliberations, decisions, activities, and internal and external communications related to the coronavirus crisis;
(8) the protection of whistleblowers who provide information about waste, fraud, abuse, or other improper activities related to the coronavirus crisis;
(9) cooperation by the executive branch and others with Congress, the Inspectors General, the Government Accountability Office, and others in connection with oversight of the preparedness for and response to the coronavirus crisis; and
